Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

P Borchmann; V Diehl; H Goergen; H Mueller; RP Mueller; HT Eich; HK Mueller-Hermelink; R Herrmann; J Markova; AD Ho; W Hiddemann; B Doerken; Richard Greil; A Engert

Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

P Borchmann
, V Diehl
, H Goergen
, H Mueller
, RP Mueller
, HT Eich
, HK Mueller-Hermelink
, R Herrmann
, J Markova
, AD Ho
, W Hiddemann
, B Doerken
, Richard Greil
, A Engert

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	717
Fachzeitschrift	BLOOD
Jahrgang	114
Ausgabenummer	22
Publikationsstatus	Veröffentlicht - 2009
Veranstaltung	51st annual meeting of the American Society of Hematology - New Orleans, LA, USA/Vereinigte Staaten Dauer: 5 Dez. 2009 → 8 Dez. 2009

Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.
Borchmann, P., Diehl, V., Goergen, H., Mueller, H., Mueller, R., Eich, H., Mueller-Hermelink, H., Herrmann, R., Markova, J., Ho, A., Hiddemann, W., Doerken, B., Greil, R. & Engert, A., 2009.
Publikation: Konferenzbeitrag › Poster

Dieses zitieren

Borchmann, P., Diehl, V., Goergen, H., Mueller, H., Mueller, RP., Eich, HT., Mueller-Hermelink, HK., Herrmann, R., Markova, J., Ho, AD., Hiddemann, W., Doerken, B., Greil, R., & Engert, A. (2009). Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial. . BLOOD , 114(22), 717.

Borchmann, P ; Diehl, V ; Goergen, H et al. / Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial. . in: BLOOD 2009 ; Jahrgang 114, Nr. 22. S. 717.

@article{e48603446a284b35978f3d11e82df2d2,

title = "Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial. ",

author = "P Borchmann and V Diehl and H Goergen and H Mueller and RP Mueller and HT Eich and HK Mueller-Hermelink and R Herrmann and J Markova and AD Ho and W Hiddemann and B Doerken and Richard Greil and A Engert",

year = "2009",

language = "English",

volume = "114",

pages = "717",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "22",

note = "51st annual meeting of the American Society of Hematology ; Conference date: 05-12-2009 Through 08-12-2009",

}

Borchmann, P, Diehl, V, Goergen, H, Mueller, H, Mueller, RP, Eich, HT, Mueller-Hermelink, HK, Herrmann, R, Markova, J, Ho, AD, Hiddemann, W, Doerken, B, Greil, R & Engert, A 2009, 'Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial. ', BLOOD , Jg. 114, Nr. 22, S. 717.

Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial. . / Borchmann, P; Diehl, V; Goergen, H et al.
in: BLOOD , Jahrgang 114, Nr. 22, 2009, S. 717.

Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

TY - JOUR

T1 - Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

AU - Borchmann, P

AU - Diehl, V

AU - Goergen, H

AU - Mueller, H

AU - Mueller, RP

AU - Eich, HT

AU - Mueller-Hermelink, HK

AU - Herrmann, R

AU - Markova, J

AU - Ho, AD

AU - Hiddemann, W

AU - Doerken, B

AU - Greil, Richard

AU - Engert, A

PY - 2009

Y1 - 2009

M3 - Abstract (Journal)

SN - 0006-4971

VL - 114

SP - 717

JO - BLOOD

JF - BLOOD

IS - 22

T2 - 51st annual meeting of the American Society of Hematology

Y2 - 5 December 2009 through 8 December 2009

ER -

Borchmann P, Diehl V, Goergen H, Mueller H, Mueller RP, Eich HT et al. Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial. . BLOOD . 2009;114(22):717.

Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

Publikationen

Combined modality treatment with intensified chemotherapy and dose-reduced involved field radiotherapy in patients with early unfavourable Hodgkin lymphoma (HL): final analysis of the German Hodgkin Study Group (GHSG) HD11 Trial.

Dieses zitieren